A Pilot Tele-rehabilitation Trial for Breast Cancer Survivors (NCT04269967) | Clinical Trial Compass
UnknownNot Applicable
A Pilot Tele-rehabilitation Trial for Breast Cancer Survivors
Singapore40 participantsStarted 2020-11-01
Plain-language summary
Breast cancer is the leading cancer affecting women in Singapore. Breast cancer survivors commonly experience declined physical function and quality of life, due to their upper limb morbidity and wound issues post-surgery. Rehabilitation therapy can address the aforementioned issues that the survivors may experience during their recovery. No therapy however, can be effective if patients do not utilize them. Home-based telehealth (e.g., tele-rehabilitation) self-managed by patients and guided by healthcare professionals can potentially improve the service use and recovery. This study aims to understand the lived experience of post-mastectomy tele-rehabilitation and recovery process among female patients who undergo a unilateral mastectomy for breast cancer.
Who can participate
Age range
21 Years – 99 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female 21 years and over
* Underwent a recent unilateral breast surgery (wide excision or simple mastectomy) with lymph nodes removed
* Speak and write English or Mandarin;
* No psychiatric history or chronic psychiatric condition as assessed by referring clinician
Exclusion Criteria:
* Having breast reconstruction
* Having legal blindness or severe visual impairment
* Having life expectancy of less than three months (12- weeks)
* Having previous upper limb injury or conditions that limit passive ranges of shoulder flexion (\<150°), elbow extension/flexion (0/145°)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The experience of rehabilitation (i.e., drain care, exercise and massage)
Timeframe: 12 weeks from the baseline assessment
2
Shoulder range of motion
Timeframe: Pre rehabilitation (week 0) and post-rehabilitation (week 12)
3
Arm circumference
Timeframe: Pre rehabilitation (week 0) and post-rehabilitation (week 12)